Bank of America’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-150,198
| Closed | -$457K | – | 7457 |
|
|
2024
Q4 | $457K | Sell |
150,198
-37,234
| -20% | -$113K | ﹤0.01% | 4785 |
|
|
2024
Q3 | $973K | Buy |
187,432
+7,481
| +4% | +$38.8K | ﹤0.01% | 4297 |
|
|
2024
Q2 | $462K | Sell |
179,951
-324,725
| -64% | -$835K | ﹤0.01% | 4625 |
|
|
2024
Q1 | $2.48M | Buy |
504,676
+296,003
| +142% | +$1.46M | ﹤0.01% | 3606 |
|
|
2023
Q4 | $1.83M | Buy |
208,673
+87,764
| +73% | +$771K | ﹤0.01% | 3713 |
|
|
2023
Q3 | $1.39M | Sell |
120,909
-161,237
| -57% | -$1.85M | ﹤0.01% | 3803 |
|
|
2023
Q2 | $7.14M | Sell |
282,146
-7,854
| -3% | -$199K | ﹤0.01% | 2584 |
|
|
2023
Q1 | $9.34M | Buy |
290,000
+114,091
| +65% | +$3.67M | ﹤0.01% | 2479 |
|
|
2022
Q4 | $3.25M | Sell |
175,909
-253,562
| -59% | -$4.68M | ﹤0.01% | 3268 |
|
|
2022
Q3 | $11.6M | Buy |
429,471
+324,549
| +309% | +$8.76M | ﹤0.01% | 2081 |
|
|
2022
Q2 | $1.45M | Buy |
104,922
+70,060
| +201% | +$968K | ﹤0.01% | 3956 |
|
|
2022
Q1 | $680K | Sell |
34,862
-76,675
| -69% | -$1.5M | ﹤0.01% | 4893 |
|
|
2021
Q4 | $1.82M | Buy |
111,537
+41,017
| +58% | +$670K | ﹤0.01% | 3994 |
|
|
2021
Q3 | $1.97M | Buy |
70,520
+1,195
| +2% | +$33.3K | ﹤0.01% | 3818 |
|
|
2021
Q2 | $2.06M | Sell |
69,325
-1,985
| -3% | -$58.9K | ﹤0.01% | 3709 |
|
|
2021
Q1 | $1.99M | Buy |
71,310
+10,702
| +18% | +$299K | ﹤0.01% | 3747 |
|
|
2020
Q4 | $1.72M | Sell |
60,608
-28,021
| -32% | -$794K | ﹤0.01% | 3521 |
|
|
2020
Q3 | $2.23M | Buy |
88,629
+31,580
| +55% | +$794K | ﹤0.01% | 3151 |
|
|
2020
Q2 | $1.39M | Buy |
57,049
+3,186
| +6% | +$77.8K | ﹤0.01% | 3458 |
|
|
2020
Q1 | $797K | Buy |
53,863
+22,192
| +70% | +$328K | ﹤0.01% | 3693 |
|
|
2019
Q4 | $514K | Sell |
31,671
-10,725
| -25% | -$174K | ﹤0.01% | 4284 |
|
|
2019
Q3 | $551K | Sell |
42,396
-199
| -0.5% | -$2.59K | ﹤0.01% | 4291 |
|
|
2019
Q2 | $553K | Sell |
42,595
-39,728
| -48% | -$516K | ﹤0.01% | 4298 |
|
|
2019
Q1 | $1.3M | Buy |
82,323
+33,270
| +68% | +$524K | ﹤0.01% | 3723 |
|
|
2018
Q4 | $987K | Sell |
49,053
-33,547
| -41% | -$675K | ﹤0.01% | 3809 |
|
|
2018
Q3 | $2.05M | Sell |
82,600
-38,157
| -32% | -$948K | ﹤0.01% | 3413 |
|
|
2018
Q2 | $3.32M | Buy |
120,757
+90,248
| +296% | +$2.48M | ﹤0.01% | 3058 |
|
|
2018
Q1 | $940K | Buy |
30,509
+21,026
| +222% | +$648K | ﹤0.01% | 3819 |
|
|
2017
Q4 | $339K | Sell |
9,483
-490
| -5% | -$17.5K | ﹤0.01% | 4414 |
|
|
2017
Q3 | $275K | Buy |
9,973
+4,220
| +73% | +$116K | ﹤0.01% | 4493 |
|
|
2017
Q2 | $151K | Sell |
5,753
-1,494
| -21% | -$39.2K | ﹤0.01% | 4700 |
|
|
2017
Q1 | $151K | Buy |
7,247
+1,651
| +30% | +$34.4K | ﹤0.01% | 4722 |
|
|
2016
Q4 | $116K | Buy |
5,596
+3,079
| +122% | +$63.8K | ﹤0.01% | 4802 |
|
|
2016
Q3 | $41K | Sell |
2,517
-1,075
| -30% | -$17.5K | ﹤0.01% | 5050 |
|
|
2016
Q2 | $49K | Buy |
3,592
+1,925
| +115% | +$26.3K | ﹤0.01% | 5044 |
|
|
2016
Q1 | $29K | Sell |
1,667
-14,259
| -90% | -$248K | ﹤0.01% | 5179 |
|
|
2015
Q4 | $544K | Buy |
15,926
+14,670
| +1,168% | +$501K | ﹤0.01% | 3891 |
|
|
2015
Q3 | $38K | Sell |
1,256
-1,200
| -49% | -$36.3K | ﹤0.01% | 5054 |
|
|
2015
Q2 | $79K | Buy |
2,456
+1,428
| +139% | +$45.9K | ﹤0.01% | 4740 |
|
|
2015
Q1 | $22K | Sell |
1,028
-3,372
| -77% | -$72.2K | ﹤0.01% | 5010 |
|
|
2014
Q4 | $75K | Buy |
4,400
+3,031
| +221% | +$51.7K | ﹤0.01% | 4684 |
|
|
2014
Q3 | $26K | Buy |
1,369
+32
| +2% | +$608 | ﹤0.01% | 5143 |
|
|
2014
Q2 | $45K | Buy |
1,337
+337
| +34% | +$11.3K | ﹤0.01% | 5052 |
|
|
2014
Q1 | $32K | Buy |
+1,000
| New | +$32K | ﹤0.01% | 4950 |
|